ZNTL240719C10000
- 0.15
- 0.000.00%
Zentalis Pharmaceuticals Newsroom
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
Zentalis Pharma's (NYSE:ZNTL) short percent of float has fallen 5.5% since its last report. The company recently reported that it has 17.51 million shares sold short, which is 49.83% of all regular sh
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersMolecular Partners (NASDAQ:MOLN) stock rose 39.1% to $11.07 during Thursday's regular session. The market value of their outstanding shares is at $367.3 million. Zentalis Pharma (NASDAQ:ZNTL) s
Express News | Zentalis Pharmaceuticals Shares Are Trading Higher After Falling on Tuesday Following a Hold Partial Clinical Hold on Partial Clinical Hold on
Express News | Zentalis Pharmaceuticals Shares up About 32%
Express News | Zentalis Pharmaceuticals Inc : UBS Cuts to Neutral From Buy
Express News | Zentalis Pharmaceuticals Inc : UBS Cuts Target Price to $5 From $28
Express News | Zentalis Pharmaceuticals Inc : Morgan Stanley Cuts to Equal-Weight
Express News | Zentalis Pharmaceuticals Inc : Morgan Stanley Cuts Target Price to $8.00 From $38.00
UBS Downgrades Zentalis Pharmaceuticals(ZNTL.US) to Hold Rating, Cuts Target Price to $5
UBS analyst Eliana Merle downgrades $Zentalis Pharmaceuticals(ZNTL.US)$ to a hold rating, and adjusts the target price from $28 to $5.According to TipRanks data, the analyst has a success rate of 40.9
Guggenheim Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Cuts Target Price to $12
Guggenheim analyst Michael Schmidt maintains $Zentalis Pharmaceuticals(ZNTL.US)$ with a buy rating, and adjusts the target price from $28 to $12.According to TipRanks data, the analyst has a success r
Wedbush Downgrades Zentalis Pharmaceuticals(ZNTL.US) to Sell Rating, Cuts Target Price to $4
Wedbush analyst Robert Driscoll downgrades $Zentalis Pharmaceuticals(ZNTL.US)$ to a sell rating, and adjusts the target price from $15 to $4.According to TipRanks data, the analyst has a success rate
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $6 to $25
On Jun 19, major Wall Street analysts update their ratings for $Zentalis Pharmaceuticals(ZNTL.US)$, with price targets ranging from $6 to $25.Morgan Stanley analyst Michael Ulz downgrades to a hold ra
Express News | Zentalis Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $8 From $15
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release,
Express News | Zentalis Pharmaceuticals Inc : Jefferies Cuts Target Price to $6 From $42
Express News | Zentalis Pharmaceuticals Inc : Jefferies Cuts to Hold From Buy
US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth
US equity markets ended higher Tuesday as traders evaluated economic macro data, including a less-than-expected retail sales growth in May. * US retail sales rose by only 0.1% in May, below a 0.3% gai
Sector Update: Health Care
Health care stocks were mixed late Tuesday afternoon with the NYSE Health Care Index fractionally lower and the Health Care Select Sector SPDR Fund (XLV) marginally higher. The iShares Biotechnology E
Top Midday Decliners
Zentalis Pharmaceuticals' (ZNTL) shares sank nearly 45% amid heavy trading after it said Tuesday the Food and Drug Administration placed a partial clinical hold on three trials for azenosertib, the co